US 12,329,763 B2
Composition of lanosterol prodrug compound, preparation method therefor and use thereof
Yizhi Liu, Guangzhou (CN); Yandong Wang, Guangzhou (CN); Xiaolin Li, Shanghai (CN); Zhi Luo, Shanghai (CN); and Haiying He, Shanghai (CN)
Assigned to Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd., Guangzhou (CN)
Appl. No. 17/435,668
Filed by Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd., Guangzhou (CN)
PCT Filed Mar. 4, 2020, PCT No. PCT/CN2020/077765
§ 371(c)(1), (2) Date Sep. 1, 2021,
PCT Pub. No. WO2020/177714, PCT Pub. Date Sep. 10, 2020.
Claims priority of application No. 201910161146.7 (CN), filed on Mar. 4, 2019.
Prior Publication US 2022/0133744 A1, May 5, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/575 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/34 (2017.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61P 27/12 (2006.01)
CPC A61K 31/575 (2013.01) [A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/34 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); A61P 27/12 (2018.01)] 18 Claims
 
1. A composition comprising a compound of formula (I) and an excipient,

OG Complex Work Unit Chemistry